Methylene blue for vasoplegic syndrome in cardiopulmonary bypass surgery: A systematic review and meta-analysis.
Fajar PerdhanaNabila Ananda KlopingAndro P WitartoDavid NugrahaNiwanda YogiswaraKevin LukeYudhistira P KlopingNancy M RehattaPublished in: Asian cardiovascular & thoracic annals (2021)
Adjunct administration of methylene blue for vasoplegic syndrome patients significantly reduces renal failure, multiple organ failure, and mortality.